The Next Frontier? ACT UP Is Now Petitioning the U.S. Senate to Start Price Negotiations For Hep C Cures With Big PharmaThe New York chapter of the AIDS Coalition to Unleash Power recently sent a letter to the U.S. Senate Finance Committee to negotiate with Gilead Sciences to establish a lower — 90% lower — price for Sovaldi (sofosbuvir), the company’s new life-changing new cure for the hepatitis C virus.Currently, the drug costs about $1,000 per pill, or nearly $84,000 for a full course of treatment and has made the pharmaceutical giant nearly $5.8 billion since the beginning of this year.
Now, what do you think would happen if somebody came out with a cure for HIV?

The Next Frontier? ACT UP Is Now Petitioning the U.S. Senate to Start Price Negotiations For Hep C Cures With Big Pharma

The New York chapter of the AIDS Coalition to Unleash Power recently sent a letter to the U.S. Senate Finance Committee to negotiate with Gilead Sciences to establish a lower — 90% lower — price for Sovaldi (sofosbuvir), the company’s new life-changing new cure for the hepatitis C virus.

Currently, the drug costs about $1,000 per pill, or nearly $84,000 for a full course of treatment and has made the pharmaceutical giant nearly $5.8 billion since the beginning of this year.

Now, what do you think would happen if somebody came out with a cure for HIV?

Research Highlights from the 20th International AIDS ConferenceFrom July 20 to 25, scientists from around the world presented all the latest research on HIV/AIDS for the AIDS 2014 conference in Melbourne, Australia. Here are some of their most major findings:
As global pandemic slows, most are still unaware of their status
100% efficacy for gays who adhered to PrEP; But most didn’t.
Sovaldi + Ribavirin show high cure rates for HIV, Hep C coinfected.
Those in poorer nations don’t drop condoms while on HIV meds
Treatment demand in poor nations continues to rise.
Donors only reach 7% of global harm reduction needs.

Research Highlights from the 20th International AIDS Conference

From July 20 to 25, scientists from around the world presented all the latest research on HIV/AIDS for the AIDS 2014 conference in Melbourne, Australia. Here are some of their most major findings:

30 Years, 9 Months, 17 Days

 Joe Burke: “[That’s when] I was diagnosed as having HIV. It wasn’t until years later in 1988 that I found out I had Hepatitis Non-A, Non-B, which at the time there were no conclusive tests or discovery of Hepatitis C. My mother got a letter in the mail no parent should be expected to receive…”

HIV Hits Massive Spike Among IDUs in Middle East/North Africa. Experts say epidemic is just beginning.

A new report shows that injection drug users in Afghanistan, Bahrain, Egypt, Iran, Morocco, Oman, Iran and Pakistan all have an HIV prevalence of up to 15 percent. In Pakistan, it’s 25 percent. And then there are countries such as Jordan, Lebanon, Palestine and Syria where HIV remains relatively rare among IDUs.

Experts also say they don’t even know how many people are passing around hepatitis C in the region along with it, but are guessing about 50 percent are infected with the blood-borne liver disease.